[HTML][HTML] Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
LS Steelman, WH Chappell, SL Abrams… - Aging (Albany …, 2011 - ncbi.nlm.nih.gov
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …
[引用][C] Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.
L Steelman, W Chappell, S Abrams, R Kempf, J Long… - AGING, 2011 - iris.unipa.it
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and
sensitivity to therapy-implications for cancer and aging. IRIS IRIS Home Sfoglia Macrotipologie …
sensitivity to therapy-implications for cancer and aging. IRIS IRIS Home Sfoglia Macrotipologie …
[HTML][HTML] Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
LS Steelman, WH Chappell, SL Abrams, CR Kempf… - Aging, 2011 - aging-us.com
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.
LS Steelman, W Chappell, SL Abrams, R Kempf… - AGING, 2011 - air.unipr.it
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.
LS Steelman, WH Chappell, SL Abrams, RC Kempf… - Aging, 2011 - europepmc.org
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …
[PDF][PDF] Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
core.ac.uk
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
LS Steelman, WH Chappell, SL Abrams, R Kempf C… - Aging, 2011 - ruj.uj.edu.pl
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
LS Steelman, WH Chappell, SL Abrams… - …, 2011 - pubmed.ncbi.nlm.nih.gov
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.
LS Steelman, WH Chappell, SL Abrams, RC Kempf… - AGING, 2011 - cris.unibo.it
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
LS Steelman, WH Chappell, SL Abrams, CR Kempf… - 2011 - thescholarship.ecu.edu
Dysregulated signaling through the Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways
is often the result of genetic alterations in critical components in these pathways or upstream …
is often the result of genetic alterations in critical components in these pathways or upstream …